584 related articles for article (PubMed ID: 12453314)
1. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
2. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
3. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis.
Riccieri V; Stefanantoni K; Vasile M; Macrì V; Sciarra I; Iannace N; Alessandri C; Valesini G
Clin Exp Rheumatol; 2011; 29(2 Suppl 65):S46-52. PubMed ID: 21586218
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
Miyashita M; Tajiri T; Yanagi K; Shimizu T; Futami R; Sasajima K; Tokunaga A
Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209
[TBL] [Abstract][Full Text] [Related]
6. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
[TBL] [Abstract][Full Text] [Related]
7. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
Feldman AL; Tamarkin L; Paciotti GF; Simpson BW; Linehan WM; Yang JC; Fogler WE; Turner EM; Alexander HR; Libutti SK
Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
[TBL] [Abstract][Full Text] [Related]
8. Serum endostatin levels are elevated in patients with soft tissue sarcoma.
Feldman AL; Pak H; Yang JC; Alexander HR; Libutti SK
Cancer; 2001 Apr; 91(8):1525-9. PubMed ID: 11301401
[TBL] [Abstract][Full Text] [Related]
9. Impaired angiogenesis as a feature of digital ulcers in systemic sclerosis.
Silva I; Almeida C; Teixeira A; Oliveira J; Vasconcelos C
Clin Rheumatol; 2016 Jul; 35(7):1743-51. PubMed ID: 26920752
[TBL] [Abstract][Full Text] [Related]
10. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
[TBL] [Abstract][Full Text] [Related]
11. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis.
Hebbar M; Peyrat JP; Hornez L; Hatron PY; Hachulla E; Devulder B
Arthritis Rheum; 2000 Apr; 43(4):889-93. PubMed ID: 10765935
[TBL] [Abstract][Full Text] [Related]
12. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.
Ma L; Elliott SN; Cirino G; Buret A; Ignarro LJ; Wallace JL
Proc Natl Acad Sci U S A; 2001 May; 98(11):6470-5. PubMed ID: 11353854
[TBL] [Abstract][Full Text] [Related]
13. Serum angiogenic activity: diagnostic relevance in renal cell carcinoma.
Beecken WD; Bentas W; Glienke W; Linneweber J; Jonas D; Binder J; Kramer W
Eur Urol; 2002 Oct; 42(4):364-9. PubMed ID: 12361902
[TBL] [Abstract][Full Text] [Related]
14. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
[TBL] [Abstract][Full Text] [Related]
15. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of angiogenic homeostasis in systemic sclerosis.
Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma.
Bono P; Teerenhovi L; Joensuu H
Cancer; 2003 Jun; 97(11):2767-75. PubMed ID: 12767089
[TBL] [Abstract][Full Text] [Related]
18. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases.
Feldman AL; Alexander HR; Bartlett DL; Kranda KC; Miller MS; Costouros NG; Choyke PL; Libutti SK
Ann Surg Oncol; 2001 Oct; 8(9):741-5. PubMed ID: 11597016
[TBL] [Abstract][Full Text] [Related]
19. Angiogenic and angiostatic factors in renal scleroderma-associated vasculopathy.
Gigante A; Navarini L; Margiotta D; Amoroso A; Barbano B; Cianci R; Afeltra A; Rosato E
Microvasc Res; 2017 Nov; 114():41-45. PubMed ID: 28602918
[TBL] [Abstract][Full Text] [Related]
20. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
